We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Horseradish Complex Increases Sensitivity of Immunochemical Assays

By LabMedica International staff writers
Posted on 01 Aug 2017
A new technique boosts the sensitivity of immunochemical reactions that rely on the enzyme horseradish peroxidase from 100 to 1,000 times.

This enhanced sensitivity is achieved by combining horseradish peroxidase (HRP), one of the most popular reporter enzymes in biology, with polydopamine (PDA), arguably the most versatile coating material for surface treatment.

Previously, a simple dip-coating protocol had been demonstrated for spontaneous formation of a thin self-adherent PDA film onto a wide range of surfaces. More...
Recently, however, investigators at the University of Washington (Seattle, USA) found that when dopamine was used in place of the typical HRP substrates, its polymerization rate increased over 300-fold. HRP aggregated dopamine molecules to form the polydopamine polymer chain. Polydopamine, in turn, accumulated on the surfaces of reaction vessels such as microtiter wells, small Petri dishes, or nanoparticles. Once the polydopamine was present, traditional protocols were followed with substantially increased test sensitivity.

PDA has been well known for its outstanding reactivity to the amine, sulfhydryl, and phenol groups in proteins, enabling site-specific deposition in the vicinity of HRP and subsequent sensitive detection based on absorption or fluorescence. Details of this approach, which the investigators called EASE (enzyme-accelerated signal enhancement), were published in the June 5, 2017, online edition of the journal Nature Biomedical Engineering.

"Common bioassays are the real workhorses of laboratory experiments and medical tests," said senior author Dr. Xiaohu Gao, professor of bioengineering at the University of Washington. "By boosting the sensitivity of these tests, we can enable more accurate medical diagnoses earlier in a disease or condition, and enable more certainty and less waste in the research process. EASE has potential to solve real, long-standing problems in research and medical tests."

"Scientists have been trying to improve the accuracy of these common tests for decades, but solutions often involve entirely new protocols or costly pieces of equipment," said Dr. Gao. "Understandably, researchers can be reluctant to invest in unfamiliar protocols or expensive new equipment -- but EASE is a simple addition to tried-and-true assays. It is like a software upgrade, instead of changing your operating system."

Related Links:
University of Washington


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.